{"code":"WIC","codeName":"Welfare and Institutions Code","section":"14195.9","citation":"Welf. & Inst. Code, § 14195.9","status":"in-force","lawOn":"2026-09-28","headings":[{"name":"DIVISION 9. PUBLIC SOCIAL SERVICES [10000. - 18999.98.]","url":"https://blackletter.si/welfare-and-institutions-code/division-9"},{"name":"PART 3. AID AND MEDICAL ASSISTANCE [11000. - 15771.]","url":"https://blackletter.si/welfare-and-institutions-code/division-9/part-3"},{"name":"CHAPTER 7. Basic Health Care [14000. - 14199.97.]","url":"https://blackletter.si/welfare-and-institutions-code/division-9/part-3/chapter-7"},{"name":"ARTICLE 6.1. Medi-Cal Therapeutic Drug Utilization Review [14195. - 14196.]","url":"https://blackletter.si/welfare-and-institutions-code/division-9/part-3/chapter-7/article-6.1"}],"history":"Added by Stats. 1984, Ch. 1636, Sec. 5.","effective":null,"html":"<p>In no case shall the director’s discretion under Section <a href=\"/wic/14120\">14120</a> be exercised to reduce reimbursement to providers of pharmaceutical services because of increased costs in the drug component of the Medi-Cal program arising from the implementation of the open formulary concept.</p>","text":"In no case shall the director’s discretion under Section 14120 be exercised to reduce reimbursement to providers of pharmaceutical services because of increased costs in the drug component of the Medi-Cal program arising from the implementation of the open formulary concept.","otherVersions":[],"url":"https://blackletter.si/welfare-and-institutions-code/medi-cal-therapeutic-drug-utilization-review-14195-9","source":"California Legislative Information bulk export (pubinfo)"}